CompanyPrivateSan Diego, CA

Iambic Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

SCHEDULE 13GNov 9Latest SEC filing

Form DSep 9$66M sold

October 2026

Iambic Therapeutics prices IPO at $16 per share, lists on Nasdaq as IAM

Oct 15FinancingIambic Therapeutics, Inc